Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lofarma is an Italian pharmaceutical company specializing in the research, development, and production of allergen-specific immunotherapies and diagnostic tools. Founded in 1945 and based in Milan, the company is recognized for its innovation in the field of allergology, particularly for its patented monomeric allergoid technology. This technology, utilized in their flagship LAIS product line, allows for effective sublingual administration with a high safety profile. Lofarma's portfolio includes a wide range of treatments for respiratory and venom allergies, as well as comprehensive diagnostic kits for skin prick testing. The company operates its own manufacturing facilities in Italy and maintains a significant presence across Europe through various subsidiaries. As a private entity, Lofarma continues to focus on personalized medicine approaches to improve the quality of life for patients suffering from allergic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lofarma Allergeni.